Risk factors for development of lethal sequelae after hepatitis B virus infection in humans
- 30 September 1984
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 77 (3) , 482-488
- https://doi.org/10.1016/0002-9343(84)90108-6
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Effects of prednisolone/azathioprine in chronic hepatitis B viral infection.Gut, 1982
- Evidence That Hepatitis B Virus Has a Role in Liver-Cell Carcinoma in Alcoholic Liver DiseaseNew England Journal of Medicine, 1982
- NATURAL HISTORY OF LIVER DISEASE IN CHRONIC HEPATITIS B SURFACE ANTIGEN CARRIERSThe Lancet, 1981
- Prednisolone in HBsAg-positive Chronic Active HepatitisNew England Journal of Medicine, 1981
- Deleterious Effect of Prednisolone in HBsAg-positive Chronic Active HepatitisNew England Journal of Medicine, 1981
- Hepatitis B viral markers in severe viral hepatitis: Influence of steroid therapyHepatology, 1981
- Hepatitis B virus markers, alpha‐fetoprotein and survival in fulminant viral hepatitisJournal of Medical Virology, 1981
- SERUM LEVELS OF HEPATITIS B SURFACE AND CORE ANTIGENS DURING IMMUNOSUPPRESSIVE TREATMENT OF HBsAg-POSITIVE CHRONIC ACTIVE HEPATITISThe Lancet, 1980
- HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.BMJ, 1978
- Histocompatibility Antigens in Active Chronic Hepatitis and Primary Biliary CirrhosisBMJ, 1974